Stories from Surgical Aesthetics
Thursday, May 31, 2018 - 13:32
Hyaluronic acid filler injections can cause persistent and recurring nodules that require combination therapies to clear. And products with a high degree of cross-linking may be more difficult to disintegrate with hyaluronidase. Authors Meredith L. Orseth MD, Nicole Lee MD, Omer Ibrahim MD, Kenneth A. Arndt MD, and Michael Kaminer MD, published two case studies of patients who experienced nodule formation after treatment with an HA filler (Journal of Drugs in Dermatology, May 2018).
Thursday, May 31, 2018 - 13:31
A recent study of Lumenis’ Inifinity 1,060nm diode laser revealed that the device is effective and offers a good safety profile for laser hair removal on all skin types. Authors Edward V. Ross, MD, Omar A. Ibrahimi, MD, and Suzanne Kilmer, MD, performed an open‐label, prospective, multi‐center study of 42 adult patients of varying skin types with dark brown or black hairs at the treatment site. Subjects underwent one of two treatment regimens. Sixteen patients had six treatments, spaced four to six weeks apart, using a chilled sapphire tip handpiece.
Thursday, May 31, 2018 - 13:28
Lauren Silvernail, former chief financial officer (CFO) and chief business officer at Revance Therapeutics, is now the CFO and executive vice president of corporate development at Evolus. Prior to her time at Revance, Silvernail served as CFO and VP of corporate development at ISTA Pharmaceuticals. She joins the company as it works towards approval of its prabotulinumtoxinA injectable (DWP-450) for the treatment of moderate-to-severe glabellar lines.
Thursday, May 31, 2018 - 13:26
A desire to better serve patients of all skin types is fueling impressive growth at the Skin of Color Society.By Inga HansenSkin typing is an important concern for aesthetic practitioners. For years, questions lingered regarding the use of injectables in patients at risk of keloid scarring, and it was only through independent research that these fears were largely laid to rest. Providers also need to look carefully at their settings when treating individuals with darker skin types with laser or energy-based devices due to an increased risk of burning and postprocedure pigmentation problems.
Thursday, May 24, 2018 - 13:52
The ingredients and science behind growth factor-based topicals.By Inga HansenGrowth factor-BASED serums and creams have become ubiquitous in topical antiaging skin care. But what these different products contain can vary widely. Some products contain actual growth factors—either animal- or plant-derived—and others use so-called “signaling” ingredients, typically peptides that trigger the cells in a manner similar to naturally occurring growth factors. In all cases, the goal is to combat the changes that occur in aging skin
Thursday, May 24, 2018 - 13:36
The U.S. Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft (Nestlé Skin Health) for the correction of age-related volume loss in the back of the hands for patients over the age of 21. It is the first HA injectable gel to be FDA-approved for restoring fullness to the back of the hands.
Thursday, May 24, 2018 - 13:32
Revance Therapeutics has established four new positions at the company as it prepares for the launch and commercialization of its daxibotulinumtoxinA injectable (RT002) for the treatment of glabellar lines.
Thursday, May 24, 2018 - 13:30
Schweiger Dermatology Group (SDG), the largest dermatology practice management company in the Northeast with 40 locations, has received an investment of $100 million from LNK Partners, a private equity firm with a long track record of investing in consumer businesses. LNK will hold a minority stake in the company, and Eric Schweiger, MD, founder and CEO, will continue to lead SDG as the company expands its footprint in the Northeast.
Thursday, May 17, 2018 - 12:29
Co-transplantation of fat with nanofat promotes neovascularization and improves fat graft survival, according to the results of a mouse study performed by Qian Yu, PhD, et al, of the department of plastic and reconstructive surgery at Shanghai 9th People’s Hospital in Shanghai, China.
Thursday, May 17, 2018 - 12:27
ALASTIN Skincare has appointed James P. Hartman to the position of chief commercial officer. Hartman most recently served as vice president and general manager at Solta Medical, a division of Valeant Pharmaceuticals. Prior to Solta, he was VP and U.S. head of aesthetics & OTC at Merz Aesthetics and VP of global marketing and business development at Obagi Medical.
Thursday, May 17, 2018 - 12:25
The approval of Evolus’ DWP-450 (prabotulinumtoxinA) has hit a snag, reportedly due to issues at the appointed manufacturing facility. The U.S. Food & Drug Administration issued a complete response letter (CRL) to the company’s biologic license application for DWP-450 outlining concerns that must be addressed before the FDA can approve the new neurotoxin for marketing in the U.S.
Thursday, May 17, 2018 - 12:23
Legal, ethical and informed consent considerations when using products off-label. By Alex R. Thiersch, JDUsing pharmaceuticals “off-label”—that is, in ways that are not specified by the United States Food and Drug Administration (FDA)—is technically legal but somewhat controversial in aesthetic medicine. Decisions regarding off-label usage should be based on current standards of care, the best interest of the patient, and your own training and expertise within the medical field. Following are some important points to consider when examining the off-label use of prescription products in your...
Thursday, May 10, 2018 - 13:00
Aesthetic physicians rightly focus on delivering optimal outcomes, but consistently good cosmetic results may not be enough to maintain positive online reviews. A special topic paper in the May 2018 issue of Plastic and Reconstructive Surgery revealed that nearly 40 percent of negative online reviews were written by people who did not undergo a procedure.
Thursday, May 10, 2018 - 12:57
eRelevance Corporation, a company that provides patient engagement technologies and services for medical practices, has launched a new service called “Response Follow-up” to help practices follow up with prospective patients who have reached out to their offices in response to promotions and marketing campaigns. The service combines phone, email and text follow-up.
Thursday, May 10, 2018 - 12:54
The Aesthetic Surgery Journal (ASJ) in conjunction with Oxford University Press will begin publishing an open access publication (a restriction- and subscription-free online research journal), titled Aesthetic Surgery Journal Open Forum in January 2019.
Tuesday, May 8, 2018 - 12:18
Dermatologist Lily Talakoub, MD, left public health for private practice so she could help patients one-on-one.By Shelley Moench-Kelly, MBAThe desire to treat patients of all ages in a one-on-one setting drew Lily Talakoub, MD, away from a career in public health and to dermatology. “I realized that my true joy in life is being with people and talking to people,” says Dr. Talakoub, who worked for the Office of the U.S. Surgeon General during medical school. “Often you follow a career path and realize that career path is not what you expected it to be. I needed to be around people. Public...
Thursday, May 3, 2018 - 10:32
A new mobile app may help improve liposuction outcomes by calculating individual patient characteristics and risk factors to reveal the maximum amount of fat that should be aspirated. Olivier A. Deigni, MD, and Henry A. Mentz, MD, presented the The Lipo Calculator as a poster at the 2018 American Society for Aesthetic Plastic Surgery conference in New York City. The Liposuction Calculator uses a formula to determine the maximum aspirated fat (Fmax) based on patient weight (W), patient height (H) and adjusted risk (Radj) using the equation:
Thursday, May 3, 2018 - 10:29
Grant Stevens, MD, FACS, plastic surgeon, founder and medical director of Marina Plastic Surgery and The OrangeTwist Institute in Marina Del Rey, California, and founder of the Orange Twist Brands, a multi-location chain for noninvasive and minimally invasive aesthetic treatments, is the new president of the American Society for Aesthetic Plastic Surgery (ASAPS).